7 Publikationen
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2977978P. Goon, et al., “Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy”, npj Vaccines, vol. 8, 2023, : 49.PUB | DOI | WoS | PubMed | Europe PMC
-
-
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2965718F. Oppel, et al., “Head and neck cancer cells can differentiate and resemble their tissue of origin”, Proceedings: AACR Annual Meeting 2022; April 8-13, 2022; New Orleans, LA, Cancer Research, vol. 82, American Association for Cancer Research (AACR), 2022, pp.111-111.PUB | DOI | WoS
-
-
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2967817F. Oppel, et al., “P28 Head and neck cancer cells differentiate resembling their tissue of origin”, Abstracts of the 4th International Symposium on HPV Infection in Head and Neck Cancer Latest Advances in Biomarker-driven Management, Amsterdam University Medical Centers, ed., Oral Oncology, vol. 134, Elsevier , 2022.PUB | DOI | WoS
-
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2965703F. Oppel, et al., “p53 pathway inactivation drives SMARCB1-deficient p53-wildtype epithelioid sarcoma onset indicating therapeutic vulnerability through MDM2 inhibition”, Molecular Cancer Therapeutics, 2022.PUB | DOI | WoS | PubMed | Europe PMC
-
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2951607F. Oppel, M. Görner, and H. Sudhoff, “The Potential of Tumor Debulking to Support Molecular Targeted Therapies”, Frontiers in Oncology, vol. 10, 2020, : 801.PUB | DOI | WoS | PubMed | Europe PMC